No study locations reported - 01 Aug `25Crisaborole with microneedling for vitiligo

Crisaborole with microneedling for vitiligo

Official title: Microneedling Combined With Topical Crisaborole 2 % Ointment in Treatment of Vitiligo. A Prospective Controlled Trial.

Status: Opening soon

Description:

Tanta University plans to enroll about 20 participants. Crisaborole is a topical PDE4 inhibitor that reduces inflammation, while microneedling may help it enter the skin. The combination may calm the local immune response and stimulate pigment return. Crisaborole is sold as Eucrisa for atopic dermatitis; vitiligo would be a new use. Possible effects include burning, stinging, redness, pain, bleeding, and rarely infection or an allergic reaction. The study record does not list an age range. Recruitment has not started, and no locations are listed yet.

Start date: August 01, 2025

Completion date: August 01, 2026

Organizer: Tanta University

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT07088276

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Crisaborole with microneedling for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Белые пятна на теле? Витилиго?

    Гид по Витилиго — ваш компас в лабиринте загадочной болезни и непростых решений. Здесь всё по-честному, по делу и на понятном языке. Вы найдёте здесь: Объяснения, что происходи...

  • What is the best therapy for localized vitiligo?

    Localized vitiligo, where the white patches are limited to one or a few areas of the body, can be managed with a few treatment approaches. The best therapy usually depends on th...

  • How Vitiligo Changes with Age?

    Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...